Unknown

Dataset Information

0

On the Rise of Cyclin-Dependent Kinase Inhibitors in Breast Cancer: Progress & Ongoing Challenges.

ABSTRACT:

SUBMITTER: Makhlin I 

PROVIDER: S-EPMC8409318 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
| S-EPMC5636177 | biostudies-literature
Unknown Gaucher disease: Progress and ongoing challenges.
| S-EPMC5425955 | biostudies-literature
Unknown Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer.
| S-EPMC6539322 | biostudies-literature
Unknown Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment.
| S-EPMC8348313 | biostudies-literature
Unknown Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics.
| S-EPMC4613943 | biostudies-literature
Unknown The Renaissance of Cyclin Dependent Kinase Inhibitors.
| S-EPMC8773807 | biostudies-literature
Unknown Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy.
| S-EPMC7919902 | biostudies-literature
Unknown Prostate cancer and PARP inhibitors: progress and challenges.
| S-EPMC8008655 | biostudies-literature
Unknown Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.
| S-EPMC6834352 | biostudies-literature
Unknown Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
| S-EPMC3309128 | biostudies-literature